
Nanomedicine-mediated alteration of the pharmacokinetic profile of small molecule cancer immunotherapeutics
Pages (881–894)
Reversal of the immunosuppressive tumor microenvironment by nanoparticle-based activation of immune-associated cells
Pages (895–901)
Nanoengineered targeting strategy for cancer immunotherapy
Pages (902–910)
Advanced biomaterials for cancer immunotherapy
Pages (911–927)
Open
Nanomedicines based on nanoscale metal-organic frameworks for cancer immunotherapy
Pages (928–935)
Open
Ex vivo pulsed dendritic cell vaccination against cancer
Pages (959–969)
Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment
Pages (970–985)
Open
Nanomedicine and cancer immunotherapy
Pages (879 – 880)